Articles

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma

Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Pathology, University of Iowa, Iowa City, IA, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Department of Pathology, University of Miami, Miami, FL, USA;
Department of Pathology, University of Miami, Miami, FL, USA;
Department of Pathology and Laboratory Medicine, United Health Services, Binghamton, NY, USA;
Division of Hematology, Mayo Clinic, Rochester, MN, USA;
Dept of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA;
Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA;
Department of Plastic Surgery, MD Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;
Haematologica Early view May 15, 2020 https://doi.org/10.3324/haematol.2019.245860